Metabolic syndrome common in young women with lupus

Metabolic syndrome common in young women with lupus

(HealthDay)—Metabolic syndrome is common in young, premenopausal women with systemic lupus erythematosus (SLE), and chloroquine appears to protect against metabolic syndrome in these women, according to a study published online Aug. 26 in Arthritis Care & Research.

Luciana F. Muniz, M.D., from Faculdade de Medicina da Universidade de Sao Paulo in Brazil, and colleagues evaluated the frequency of and disease- or therapy-related factors in 103 premenopausal SLE patients (<40 years) and 35 healthy, premenopausal, age-matched women.

The researchers found a higher frequency of metabolic syndrome in the SLE group (22.3 percent versus 5.7 percent; P=0.03). Compared with those without metabolic syndrome, SLE patients with metabolic syndrome had higher SLE Disease Activity Index scores (P=0.006), more frequently had previous renal disease (73.9 percent versus 51.2 percent; P=0.05) and current renal disease (34.8 percent versus 10 percent; P=0.008), and had higher current prednisone dose (P=0.018) and cumulative prednisone dose (P=0.023). Chloroquine was less frequently used in metabolic syndrome-SLE patients (65.2 percent versus 90 percent; P=0.008). In multivariate analysis, only current chloroquine use (prevalence ratio [PR], 0.29) and cumulative prednisone were associated with metabolic syndrome (PR, 1.02).

"Chloroquine has a protective effect on the prevalence of metabolic syndrome in these patients, and this benefit counteracts the deleterious effect of glucocorticoids in a dose-dependent manner," the authors conclude.

More information: Abstract
Full Text (subscription or payment may be required)

Journal information: Arthritis Care & Research

Copyright © 2015 HealthDay. All rights reserved.

Citation: Metabolic syndrome common in young women with lupus (2015, September 17) retrieved 28 March 2024 from https://medicalxpress.com/news/2015-09-metabolic-syndrome-common-young-women.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Pediatric discoid lupus carries significant progression risk

8 shares

Feedback to editors